Explore
Trendline
Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026
Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026
Read More
Trendline
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions
Read More
Trendline
Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026
Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026
Read More
Trendline
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Submissions
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Submissions
Read More
Trendline
IDEAYA Biosciences to Present Phase 2/3 Trial Data on Darovasertib at ASCO 2026
IDEAYA Biosciences to Present Phase 2/3 Trial Data on Darovasertib at ASCO 2026
Read More
Trendline
IDEAYA Biosciences to Present Phase 2/3 Data on Darovasertib at ASCO 2026
IDEAYA Biosciences to Present Phase 2/3 Data on Darovasertib at ASCO 2026
Read More
Trendline
MSD and Eisai Face Setback in Kidney Cancer Trial with Welireg
MSD and Eisai Face Setback in Kidney Cancer Trial with Welireg
Read More
Trendline
Inhibrx to Provide Clinical Update on Ozekibart for Colorectal Cancer in Webcast
Inhibrx to Provide Clinical Update on Ozekibart for Colorectal Cancer in Webcast
Read More
Trendline
Obsidian Therapeutics to Present Phase 2 Data on OBX-115 for Advanced Melanoma at ASCO 2026
Obsidian Therapeutics to Present Phase 2 Data on OBX-115 for Advanced Melanoma at ASCO 2026
Read More
Trendline
Pfizer Showcases Oncology Innovations at ASCO 2026, Highlighting New Standards of Care
Pfizer Showcases Oncology Innovations at ASCO 2026, Highlighting New Standards of Care
Read More
Trendline
Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence
Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence
Read More
Trendline
Revolution Medicine's Pancreatic Cancer Trial Results Boost Stock Value
Revolution Medicine's Pancreatic Cancer Trial Results Boost Stock Value
Read More
